Lytix Biopharma AS (6BG)
Market Closed
7 Aug, 20:00
XFRA XFRA Primary 
XOSL €
0. 74
+0.02
+2.507%
€
59.21M Market Cap
- P/E Ratio
- Div Yield
5,000 Volume
-2.26 Eps
€ 0.72
Previous Close Want to track 6BG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lytix Biopharma AS (6BG) Statistics
Valuation metrics
Market Cap 59.21M
Enterprise value -658.14K
Trailing P/E (ttm) -1.13
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) -
Price/Book (mrq) 11.25
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.11
Overview
Shares outstanding 68.59M
Float 34.43M
Shares short -
% Held by insiders 0.53%
% Held by institutions 0.05%
Average volume (10 days) 1K
Average volume (90 days) 2.5K
Price summary
52-Week low 0.57
52-Week high 1.01
Beta -0.5
50-Day moving average 0.92
200-Day moving average 0.79
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.35%
Return on equity -0.71%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -5.94M
Net income to common (ttm) -5.57M
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 6.72M
Total cash per share (mrq) 1.06
Total debt (mrq) 204.27K
Total Debt/Equity (mrq) 3.56
Current ratio (mrq) 4.28%
Book value per share (mrq) 0.08
Cash Flow
Cash flow statement -5.56M
Levered free cash flow (LFCF) -3.5M
